Jun 23, 2022 / NTS GMT
Operator
Good day, ladies and gentlemen, and welcome to Redx's webcast covering the company's interim results for the six months ended March 31, 2022. (Operator Instructions)
I will now hand over to Rachel Curtis Gravesen to open the call.
Rachel Curtis Gravesen - Curtis Consult - IR
Good morning and good afternoon. Thank you for joining us today for the call to discuss Redx's interim results for the six months ended March 31, 2022. I'm Rachel Curtis Gravesen. And in a moment, I'll hand over to Redx's Chief Executive Officer, Lisa Anson; Chief Financial Officer for the company, Peter Collum; and the Chief Scientific Officer, Richard Armer; who will all present the progress made during the period by the company.
After the presentation, we'll hold a Q&A session. And Dr. Jane Robertson, who's the company's Chief Medical Officer, will also participate in that session together with the other presenters. (Conference instructions)
At that point, though, I'd like you to move to the next slide, please. And because before we begin, I'd like to draw
Half Year 2022 Redx Pharma PLC Earnings Call Transcript
Jun 23, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers